J-GLOBAL ID:201301084816890390   Update date: Sep. 03, 2019

Jun Ooi

オオイ ジュン | Jun Ooi
Affiliation and department:
Research field  (1): Hematology
Research theme for competitive and other funds  (5):
  • 2009 - 2011 Functional differences between malignant niche on the process of leukemia/lymphoma progression and hematopoietic stem cell niche on the process of cord blood graft engraftment
  • 2009 - 2011 Detection of VSEL cells in umbilical cord blood and development of co-culture system with umbilical cord-derived mesehchymal stem cells
  • 2007 - 2008 Development of new strategy for cord blood transplantation using enhancedleukemia-specific immune response with donor T cell
  • 2002 - 2003 Development of cancer immunogene therapy with gene-modified adenoviral vector re-targeted by tumor-specific peptides
  • 1999 - 2002 Feasibility of MARCO(Mitochondrial antisense RNA for cytochrome C Oxidase) for the treatment of leukerniaz
Papers (86):
  • Tanoue S, Konuma T, Takahashi S, Watanabe E, Sato N, Watanabe N, Isobe M, Kato S, Ooi J, Tojo A. Long-term persistent donor-recipient mixed chimerism without disease recurrence after myeloablative single-unit cord blood transplantation in adult acute myeloid leukemia following myelodysplastic syndrome. Leukemia & lymphoma. 2017
  • Konuma T, Kato S, Ooi J, Ebihara Y, Mochizuki S, Ishii H, Takei T, Oiwa-Monna M, Tojo A, Takahashi S. Second allogeneic transplantation using unrelated cord blood for relapsed hematological malignancies after allogeneic transplantation. Leukemia & lymphoma. 2015
  • Tanaka M, Kanamori H, Matsumoto K, Tachibana T, Numata A, Ohashi K, Kobayashi T, Nakaseko C, Kanda Y, Yamazaki E, Fujisawa S, Ooi J, Sakura T, Kanto Study Group for Cell Therapy. Clinical significance of pretransplant serum ferritin on the outcome of allogeneic hematopoietic SCT: a prospective cohort study by the Kanto Study Group for Cell Therapy. Bone marrow transplantation. 2015
  • Konuma T, Kato S, Ooi J, Ebihara Y, Mochizuki S, Oiwa-Monna M, Tojo A, Takahashi S. Third allogeneic stem cell transplantation (SCT) using unrelated cord blood for relapsed acute leukemia after second allogeneic SCT. International journal of hematology. 2015
  • Konuma T, Ooi J, Uchida N, Ogawa H, Ohashi K, Kanamori H, Aotsuka N, Onishi Y, Yamaguchi H, Kozai Y, Nagamura-Inoue T, Kato K, Suzuki R, Atsuta Y, Kato S, Asano S, Takahashi S. Granulocyte colony-stimulating factor combined regimen in cord blood transplantation for acute myeloid leukemia: a nationwide retrospective analysis in Japan. Haematologica. 2014. 99. e264-8
Books (1):
  • Umbilical Cord Blood Banking and Transplantation (Stem Cell Biology and Regenerative Medicine)
    Springer 2014 ISBN:3319064436
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page